Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 7/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 7/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 7/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 3/20 | 0.36 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | GUSB | P08236 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28179503 | 0.77 | GNAI3 (0.33) | GNAI3GNAO1GNAI1BCHECPB2 | |
| SCHEMBL29028694 | 0.71 | GBA1 (0.39) | GNAI3GNAO1GNAI1BCHEGBA1 | |
| SCHEMBL8197075 | 0.69 | KCNH2 (0.36) | GNAI3GNAO1GNAI1KCNH2BCHE | |
| SCHEMBL139702 | 0.69 | GUSB (0.37) | BCHECPB2GBA1GUSB | |
| SCHEMBL5711571 | 0.68 | GNAI3 (0.37) | GNAI3GNAO1GNAI1KCNH2BCHE | |
| SCHEMBL28110693 | 0.68 | CPB2 (0.36) | BCHECPB2 | |
| SCHEMBL18187498 | 0.66 | GUSB (0.37) | KCNH2BCHEGBA1GUSB | |
| SCHEMBL10818617 | 0.64 | L3MBTL1 (0.38) | BCHE | |
| SCHEMBL454182 | 0.64 | S1PR1 (0.41) | KCNH2BCHE | |
| SCHEMBL6060680 | 0.64 | AKT1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11083685-B2 | Methods for treating scars and aging skin | ALLERGAN, INC. (US) | 2021-08-10 | — | — | US | disclosed |
| US-20160058816-A1 | METHODS FOR TREATING SCARS AND AGING SKIN | ALLERGAN, INC. | 2016-03-03 | — | — | US | disclosed |
| US-20160058693-A1 | METHODS FOR TREATING SCARS AND AGING SKIN | ALLERGAN INC (US) | 2016-03-03 | — | — | US | disclosed |
| US-9180158-B2 | Methods for treating scars and aging skin | ALLERGAN, INC. | 2015-11-10 | — | — | US | disclosed |
| US-9180157-B2 | Methods for treating scars and aging skin | ALLERGAN, INC. | 2015-11-10 | — | — | US | disclosed |
| US-20130337088-A1 | METHODS FOR TREATING SCARS AND AGING SKIN | ALLERGAN, INC. | 2013-12-19 | — | — | US | disclosed |
| US-8591961-B2 | Aesthetic treatment of scars and aging skin | ALLERGAN, INC. (US) | 2013-11-26 | — | — | US | disclosed |
| US-20120058167-A1 | METHODS FOR TREATING SCARS AND AGING SKIN | ALLERGAN, INC. | 2012-03-08 | — | — | US | disclosed |
| US-20120058076-A1 | AESTHETIC TREATMENT OF SCARS AND AGING SKIN | ALLERGAN, INC. | 2012-03-08 | — | — | US | disclosed |